Oncology Radiologists are medical imaging specialists who play a crucial role in the detection, diagnosis, staging, and monitoring of cancer. Using advanced imaging technologies such as CT scans, MRIs, PET scans, ultrasound, and mammography, they help identify tumors, determine their size and spread, and evaluate how cancer responds to treatment. Their detailed interpretations provide vital information that guides clinical decision-making and helps oncologists develop the most effective treatment plans. In many cases, oncology radiologists are the first to detect abnormalities that lead to a cancer diagnosis. Their expertise ensures that even subtle changes in imaging are recognized, allowing for early intervention and more favorable outcomes. As imaging technology evolves, radiologists continue to integrate AI and machine learning tools to improve diagnostic accuracy.
Oncology radiologists also perform image-guided procedures, such as biopsies and tumor ablations, contributing to both minimally invasive diagnosis and treatment. They work closely with oncologists, surgeons, and pathologists to provide a comprehensive understanding of each patient's condition. With the rise of precision medicine, oncology radiologists are increasingly involved in tracking biomarkers and tumor characteristics over time through advanced imaging techniques. Their ability to visualize and interpret internal structures accurately makes them essential to personalized cancer management. By maintaining open communication with the care team, they help ensure that treatment decisions are timely, data-driven, and patient-centered.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China